The Biden administration announced Friday that popular weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations with manufacturers.

Diana Collette went from size 16 to size 10 on weight loss drug Mounjaro. She coped well with the side effects too – nausea ...

Jan 17 (Reuters) - The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Saving more, paying down debt and building wealth are top financial goals for many Americans. CNBC's Senior Personal Finance Correspondent Sharon Epperson and Anchor Kelly Evans share advice on how to ...

GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

The Centers for Medicare & Medicaid Services just announced 15 new drugs it wants to lower the cost for including popular, ...

Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.